Aquestive Therapeutics Inc (AQST)
5.15
-0.37
(-6.70%)
USD |
NASDAQ |
Nov 04, 16:00
5.03
-0.12
(-2.33%)
After-Hours: 20:00
Aquestive Therapeutics EBIT Margin (TTM)
EBIT Margin (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EBIT Margin (TTM) Data
Date | Value |
---|---|
June 30, 2024 | -- |
March 31, 2024 | -- |
December 31, 2023 | -- |
September 30, 2023 | -- |
June 30, 2023 | -- |
March 31, 2023 | -- |
December 31, 2022 | -- |
September 30, 2022 | -- |
June 30, 2022 | -- |
March 31, 2022 | -- |
December 31, 2021 | -- |
September 30, 2021 | -- |
June 30, 2021 | -- |
March 31, 2021 | -- |
Date | Value |
---|---|
December 31, 2020 | -- |
September 30, 2020 | -- |
June 30, 2020 | -- |
March 31, 2020 | -- |
December 31, 2019 | -- |
September 30, 2019 | -- |
June 30, 2019 | -- |
March 31, 2019 | -- |
December 31, 2018 | -- |
September 30, 2018 | -- |
June 30, 2018 | -- |
March 31, 2018 | -- |
December 31, 2017 | -- |
EBIT Margin Definition
An EBIT Margin is the operating earnings over operating sales. This margin allows investors to understand true business costs of running a company, because parts of a company's property, plant, and equipment will eventually need to be replaced as they get used, broken down, decayed, etc.